Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Gemma Biotherapeutics

Request full access

Accelerating global access to advanced gene therapies for rare diseases through innovative research and international coalitions

Philadelphia, United StatesFounded 2024Biotech & Life Sciences

About Gemma Biotherapeutics

GEMMABio is a therapeutics company focused on accelerating the research and global accessibility of advanced gene therapies for rare diseases. The company collaborates with international coalitions and operates alongside Franklin Biolabs to expedite the development and delivery of life-changing treatments. GEMMABio's business model is centered around research and innovation, aiming to bring new gene therapies to market faster. The company generates revenue through the commercialization of its gene therapy platforms, which include three FDA-approved AAV-based gene therapies and numerous active programs in development. GEMMABio serves patients suffering from rare diseases, providing them with cutting-edge treatments that are otherwise unavailable. The market it operates in is the biotechnology and gene therapy sector, which is highly specialized and rapidly evolving. The company's success is driven by its extensive patent portfolio and its ability to bring new therapies from the bench to the bedside efficiently.

Source: Dealroom company data

At a glance

Status
Operational
Employees
65
Open positions
2
Dealroom signal
27.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Disease, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANT✓Other financing Jul 2026 $0 — Advanced Research Projects Agency for Health - ARPA-H ↗
SEED✓Equity / VC Dec 2024 $34M $136M Bioluminescence Ventures · Earlybird Venture Capital · Double Point Ventures ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Gemma Biotherapeutics website traffic

Latest recorded traffic for Gemma Biotherapeutics is 5.1K monthly website visits, up 264.3% over the last three months.

Latest monthly visits5.1K 3-month web change+264.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Gemma Biotherapeutics in the Philadelphia ecosystem

Live from Dealroom

The Gemma Biotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

  • Fiocruz
  • Bioluminescence Ventures
  • Earlybird Venture Capital
  • Double Point Ventures
  • Advanced Research Projects Agency for Health - ARPA-H
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇺🇸 United States91.1%
🇬🇧 United Kingdom3.6%
🇩🇪 Germany1.8%
🇨🇭 Switzerland1.8%
🇨🇦 Canada1.8%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Gemma Biotherapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Gemma Biotherapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.